Introduction. Transfusion-associated infections with hepatitis C virus (HCV) are seen in 1:28,000 to 1:288,000 cases per transfused blood unit in Germany today, infections with hepatitis B virus (HBV) and human immunodeficiency virus (HIV) in about 1:147,000 to 1:31,000 and 1:2 Mio to 1:200,000 cases, respectively. Under their immunosuppressive therapy oncologic patients acquire a HCV- or HBV-infection easily and infection takes a chronic course.  
